Contributions of immune cell populations in the maintenance, progression, and therapeutic modalities of glioma
| العنوان: | Contributions of immune cell populations in the maintenance, progression, and therapeutic modalities of glioma |
|---|---|
| المؤلفون: | Stella E. Tsirka, Michael D. Caponegro, Jeremy T. Miyauchi |
| المصدر: | AIMS allergy and immunology AIMS Allergy and Immunology, Vol 2, Iss 1, Pp 24-44 (2018) |
| سنة النشر: | 2018 |
| مصطلحات موضوعية: | lcsh:Immunologic diseases. Allergy, medicine.medical_treatment, glioma TME, Ocean Engineering, Context (language use), Disease, Article, neuropilin 1, Immune system, Immunity, Glioma, Neuropilin 1, medicine, GAMs, Safety, Risk, Reliability and Quality, business.industry, T Cells, Cancer, Immunotherapy, biochemical phenomena, metabolism, and nutrition, medicine.disease, Cancer research, bacteria, immunotherapy, business, lcsh:RC581-607 |
| الوصف: | Immunotherapies are becoming a promising strategy for malignant disease. Selectively directing host immune responses to target cancerous tissue is a milestone of human health care. The roles of the innate and adaptive immune systems in both cancer progression and elimination are now being realized. Defining the immune cell environment and identifying the contributions of each sub-population of these cells has lead to an understanding of the immunotherapeutic processes, and demonstrated the potential of the immune system to drive cancer shrinkage and sustained immunity against disease. Poorly treated diseases, such as high-grade glioma, suffer from lack of therapeutic efficacy and rapid progression. Immunotherapeutic success in other solid malignancies, such as melanoma, now provides the principals for which this treatment paradigm can be adapted for primary brain cancers. The central nervous system is complex, and relative contributions of immune sub-populations to high grade glioma progression are not fully characterized. Here, we summarize recent research in both animal and humans which add to the knowledge base of how innate and adaptive immune cells contribute to glioma progression, and outline work which has demonstrated their potential to elicit anti-tumorigenic responses. Additionally, we highlight Neuropilin 1, a cell surface receptor protein, describe its signaling functions in the context of immunity, and point to its potential to slow glioma progression. |
| اللغة: | English |
| تدمد: | 2575-615X |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9de4cd30a0ae30a822517e2844d9bd2dTest http://europepmc.org/articles/PMC7480949Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....9de4cd30a0ae30a822517e2844d9bd2d |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 2575615X |
|---|